1. |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 2015, 136(5): E359-E386.
|
2. |
张耕源, 罗长江, 龙勃, 等. 含多西他赛的新辅助化疗治疗进展期胃癌有效性和安全性的 Meta 分析. 中国普通外科杂志, 2016, 25(10): 1388-1396.
|
3. |
陈国宁, 蔡茂怀. 紫杉醇、奥沙利铂联合榄香烯腹腔灌注治疗胃癌晚期癌性腹水的临床观察. 中国药房, 2016, 27(36): 5095-5097.
|
4. |
Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, et al. The global burden of cancer 2013. JAMA Oncol, 2015, 1(4): 505-527.
|
5. |
Bacigalupo ML, Carabias P, Troncoso MF. Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression. World J Gastroenterol, 2017, 23(29): 5266-5281.
|
6. |
Long B, Yu Z, Zhou H, et al. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis. Int J Surg, 2018, 56: 242-249.
|
7. |
Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med, 2008, 10: e17.
|
8. |
Lau KS, Dennis JW. N-Glycans in cancer progression. Glycobiology, 2008, 18(10): 750-760.
|
9. |
Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer, 2005, 5(1): 29-41.
|
10. |
李富新. 半乳糖凝集素 1 与胃癌侵袭转移的相关性研究. 天津医科大学, 2007.
|
11. |
Blaževitš O, Mideksa YG, Šolman M, et al. Galectin-1 dimers can scaffold Raf-effectors to increase H-ras nanoclustering. Sci Rep, 2016, 6: 24165.
|
12. |
Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, et al. Unraveling galectin-1 as a novel therapeutic target for cancer. Cancer Treat Rev, 2014, 40(2): 307-319.
|
13. |
Rabinovich GA, Conejo-García JR. Shaping the immune landscape in cancer by galectin-driven regulatory pathways. J Mol Biol, 2016, 428(16): 3266-3281.
|
14. |
Jorge YC, Mataruco MM, Araújo LP, et al. Expression of annexin-A1 and galectin-1 anti-inflammatory proteins and mRNA in chronic gastritis and gastric cancer. Mediators Inflamm, 2013, 2013: 152860.
|
15. |
He XJ, Tao HQ, Hu ZM, et al. Expression of galectin-1 in carcinoma-associated fibroblasts promotes gastric cancer cell invasion through upregulation of integrin β1. Cancer Sci, 2014, 105(11): 1402-1410.
|
16. |
Zheng L, Xu C, Guan Z, et al. Galectin-1 mediates TGF-β-induced transformation from normal fibroblasts into carcinoma-associated fibroblasts and promotes tumor progression in gastric cancer. Am J Transl Res, 2016, 8(4): 1641-1658.
|
17. |
吕宜梅. 半乳糖凝集素家族与肿瘤的研究进展. 实用妇科内分泌电子杂志, 2016, 3(10): 54-56.
|
18. |
赵艳, 金鑫, 李楠, 等. ALDH1、CXCR4、E-cadherin 在胃癌组织中的表达及与淋巴结转移的关系. 南方医科大学学报, 2016, 36(10): 1390-1395.
|
19. |
Chong Y, Tang D, Gao J, et al. Galectin-1 induces invasion and the epithelial-mesenchymal transition in human gastric cancer cells via non-canonical activation of the hedgehog signaling pathway. Oncotarget, 2016, 7(50): 83611-83626.
|
20. |
Chen J, Tang D, Wang S, et al. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients. Tumour Biol, 2014, 35(3): 2513-2519.
|
21. |
You X, Wang Y, Wu J, et al. Prognostic significance of galectin-1 and vasculogenic mimicry in patients with gastric cancer. Onco Targets Ther, 2018, 11: 3237-3244.
|
22. |
Estofolete CF, Zucoloto S, Oliani SM, et al. Myenteric denervation downregulates galectin-1 and -3 expression in gastric carcinogenesis. Dig Dis Sci, 2011, 56(6): 1637-1644.
|
23. |
Polli-Lopes AC, Zucoloto S, de Queirós Cunha F, et al. Myenteric denervation reduces the incidence of gastric tumors in rats. Cancer Lett, 2003, 190(1): 45-50.
|
24. |
Tang D, Gao J, Wang S, et al. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression. Tumour Biol, 2016, 37(2): 1889-1899.
|
25. |
Lim JW, Kim H, Kim KH. Cell adhesion-related gene expression by Helicobacter pylori in gastric epithelial AGS cells. Int J Biochem Cell Biol, 2003, 35(8): 1284-1296.
|
26. |
Chen YR, Juan HF, Huang HC, et al. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells. J Proteome Res, 2006, 5(10): 2727-2742.
|
27. |
Chong Y, Tang D, Xiong Q, et al. Galectin-1 from cancer-associated fibroblasts induces epithelial-mesenchymal transition through β1 integrin-mediated upregulation of Gli1 in gastric cancer. J Exp Clin Cancer Res, 2016, 35(1): 175.
|
28. |
李明辉, 董永杰, 赵静雅, 等. SIRT-1 及 E-cadherin 在胃癌组织中表达的相关研究. 中国普外基础与临床杂志, 2018, 25(1): 42-47.
|
29. |
Yoshii M, Tanaka H, Ohira M, et al. Expression of Forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach. Br J Cancer, 2012, 106(10): 1668-1674.
|
30. |
Zhao Y, Li J, Xing Y, et al. N-acetylglucosaminyltransferase Ⅴ mediates cell migration and invasion of mouse mammary tumor cells 4TO7 via RhoA and Rac1 signaling pathway. Mol Cell Biochem, 2008, 309(1-2): 199-208.
|
31. |
Pinho SS, Figueiredo J, Cabral J, et al. E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases Ⅲ and Ⅴ. Biochim Biophys Acta, 2013, 1830(3): 2690-2700.
|
32. |
Taniguchi N, Korekane H. Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. BMB Rep, 2011, 44(12): 772-781.
|
33. |
Croci DO, Cerliani JP, Dalotto-Moreno T, et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell, 2014, 156(4): 744-758.
|
34. |
文静, 任孟军, 谭伟. 亚洲人群环氧化酶-2 基因多态性与胃癌关联性的系统性回顾与 Meta 分析. 重庆医科大学学报, 2016, 41(6): 609-613.
|
35. |
Zhao Q, Li Y, Huang J, et al. Short-term curative effect of S-1 plus oxaliplatin as perioperative chemotherapy for locally advanced gastric cancer: a prospective comparison study. Pharmazie, 2017, 72(4): 236-240.
|
36. |
李延武, 张有成. 胃癌淋巴结转移及其组织病理特征的回顾性研究. 中国普外基础与临床杂志, 2017, 24(5): 572-579.
|
37. |
张耕源, 杜恒锐, 王振江, 等. 多西他赛在胃癌治疗中的研究进展. 中南大学学报(医学版), 2018, 43(2): 216-221.
|
38. |
Chen JW, Luo YJ, Yang ZF, et al. Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer. Oncol Rep, 2018, 39(4): 1739-1746.
|